<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091961</url>
  </required_header>
  <id_info>
    <org_study_id>R-09-487</org_study_id>
    <secondary_id>16503</secondary_id>
    <nct_id>NCT01091961</nct_id>
  </id_info>
  <brief_title>Study of Preoperative Management of Angiotensin Converting Enzyme Inhibitor (ACEi) and Angiotensin Receptor Blocker (ARB) Medications</brief_title>
  <acronym>PASS</acronym>
  <official_title>Pre-Operative Inhibition of the Angiotensin System Study: A Prospective Randomized Single-Blinded Trial of Pre-Operative Management of Medications That Inhibit the Renin-Angiotensin System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients on a stable dose of ACE inhibitor or ARB medication who are scheduled for elective
      surgery will be randomized to take their ACE inhibitor or ARB up to and including the morning
      of surgery, or to hold them a day prior to the surgery. The patients will be followed for 30
      days after surgery to assess any adverse health outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinically significant hypotension</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically significant hypertension</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular morbidity</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Continuing ACEi/ARB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will continue to take their chronic ACEi/ARB medications up to and including the day of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Holding ACEi/ARB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will hold their chronic ACEi/ARB medication at least 24 hours prior to surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Preoperative ACEi/ARB management</intervention_name>
    <description>Patients will either hold their chronic ACEi/ARB medication for at least 24 hours prior to surgery, or continue to take the ACEi/ARB medication up to and including the day of surgery</description>
    <arm_group_label>Continuing ACEi/ARB</arm_group_label>
    <arm_group_label>Holding ACEi/ARB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  currently taking an ACEi, ARB or both

          -  no change in these medications during the two weeks prior to study enrollment

          -  scheduled for non-cardiac surgery requiring regional or general anesthesia

          -  minimum overnight anticipated length of stay

          -  age ≥18 years.

        Exclusion Criteria:

          -  explicit instructions provided to patient by surgical team regarding the perioperative
             management of ACEi or ARB

          -  significant hypertension in pre-operative assessment clinic (systolic blood pressure
             ≥180 mmHg OR diastolic blood pressure ≥110 mmHg)

          -  significant hypotension in pre-operative assessment clinic (systolic blood pressure &lt;
             90 mmHg)

          -  prior enrollment in the study

          -  participation in another research study of antihypertensive medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marko Mrkobrada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Western Ontario, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2010</study_first_submitted>
  <study_first_submitted_qc>March 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <last_update_submitted>August 24, 2017</last_update_submitted>
  <last_update_submitted_qc>August 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <name_title>Marko Mrkobrada/Principal Investigator</name_title>
    <organization>University of Western Ontario</organization>
  </responsible_party>
  <keyword>ACE inhibitor</keyword>
  <keyword>ARB</keyword>
  <keyword>Non-cardiac surgery</keyword>
  <keyword>Perioperative</keyword>
  <keyword>Preoperative</keyword>
  <keyword>Hypotension</keyword>
  <keyword>Congestive heart failure</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Angiotensin-Converting Enzyme Inhibitors</keyword>
  <keyword>Angiotensin II Type 1 Receptor Blockers</keyword>
  <keyword>Perioperative Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enzyme Inhibitors</mesh_term>
    <mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
    <mesh_term>Angiotensin Receptor Antagonists</mesh_term>
    <mesh_term>Angiotensin II Type 1 Receptor Blockers</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

